Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2019 May 23;20(1):101.
doi: 10.1186/s12931-019-1049-3.

Spirometric assessment of emphysema presence and severity as measured by quantitative CT and CT-based radiomics in COPD

Affiliations
Multicenter Study

Spirometric assessment of emphysema presence and severity as measured by quantitative CT and CT-based radiomics in COPD

Mariaelena Occhipinti et al. Respir Res. .

Abstract

Background: The mechanisms underlying airflow obstruction in COPD cannot be distinguished by standard spirometry. We ascertain whether mathematical modeling of airway biomechanical properties, as assessed from spirometry, could provide estimates of emphysema presence and severity, as quantified by computed tomography (CT) metrics and CT-based radiomics.

Methods: We quantified presence and severity of emphysema by standard CT metrics (VIDA) and co-registration analysis (ImbioLDA) of inspiratory-expiratory CT in 194 COPD patients who underwent pulmonary function testing. According to percentages of low attenuation area below - 950 Hounsfield Units (%LAA-950insp) patients were classified as having no emphysema (NE) with %LAA-950insp < 6, moderate emphysema (ME) with %LAA-950insp ≥ 6 and < 14, and severe emphysema (SE) with %LAA-950insp ≥ 14. We also obtained stratified clusters of emphysema CT features by an automated unsupervised radiomics approach (CALIPER). An emphysema severity index (ESI), derived from mathematical modeling of the maximum expiratory flow-volume curve descending limb, was compared with pulmonary function data and the three CT classifications of emphysema presence and severity as derived from CT metrics and radiomics.

Results: ESI mean values and pulmonary function data differed significantly in the subgroups with different emphysema degree classified by VIDA, ImbioLDA and CALIPER (p < 0.001 by ANOVA). ESI differentiated NE from ME/SE CT-classified patients (sensitivity 0.80, specificity 0.85, AUC 0.86) and SE from ME CT-classified patients (sensitivity 0.82, specificity 0.87, AUC 0.88).

Conclusions: Presence and severity of emphysema in patients with COPD, as quantified by CT metrics and radiomics can be estimated by mathematical modeling of airway function as derived from standard spirometry.

Keywords: Area under curve; COPD; Pulmonary emphysema; Radiomics; Respiratory function tests; Small airway disease; Spirometry; Tomography.

PubMed Disclaimer

Conflict of interest statement

Dr. Occhipinti reports personal fees from Imbio LLC, grants from Menarini Foundation, outside the submitted work.

Dr. Bartholmai reports personal fees from Promedior, LLC, and from Imbio, LLC, outside the submitted work. Mayo Clinic has received grants from NIH/NHLBI, fees from Imbio, LLC, and Boehringer Ingelheim outside the submitted work. In addition, Dr. Bartholmai has a patent SYSTEMS AND METHODS FOR ANALYZING IN VIVO TISSUE VOLUMES USING MEDICAL IMAGING pending to Mayo Clinic.

Dr. Karwoski reports other from Imbio Inc., outside the submitted work.

Dr. Lavorini reports personal fees from Chiesi Farmaceutici, grants and personal fees from Menarini International, personal fees from GlaxoSmithKline, personal fees from Boehringer Ingelheim, personal fees from Orion Pharma, personal fees from Novartis, outside the submitted work.

Dr. Pistolesi reports grants from MINISTRY OF HEALTH OF ITALY, grants from MINISTRY OF UNIVERSITY AND RESEARCH OF ITALY, during the conduct of the study; personal fees and non-financial support from GSK, grants, personal fees and non-financial support from MENARINI, personal fees and non-financial support from BOEHRINGER IINGELHEIM, personal fees and non-financial support from ASTRAZENECA, personal fees and non-financial support from CHIESI, grants, personal fees and non-financial support from MUNDIPHARMA, personal fees and non-financial support from BIOFUTURA, grants, personal fees and non-financial support from NOVARTIS, personal fees and non-financial support from GUIDOTTI MALESCI, personal fees from MENARINI INTERNATIONAL, grants from SANOFI, grants and personal fees from MSD, personal fees and non-financial support from GRIFOLS, grants from BAYER, outside the submitted work.

M Paoletti, SR, CN, ARL, RI, GC, SC have no competing interests.

Figures

Fig. 1
Fig. 1
Lung parenchyma representations at CT scan after post-processing with different software programs in a patient with severe emphysema. a. Axial CT scan shows advanced destructive emphysema with a giant bulla in the right lower lobe adjacent to an area of passive atelectasis. b. Volume rendering of the densitometric analysis performed by VIDA shows the location and severity of emphysema at inspiratory scan (threshold -950HU) displaying spheres whose diameter is proportional to the relative volume of emphysema in each region. c-d. Coronal and Sagittal 2D images obtained by co-registration of inspiratory and expiratory CT scans by Imbio LDA show the location of emphysema (red), functional airways gas trapping (yellow), and normal lung (green). e. Volume rendering of the lung texture analysis performed by CALIPER shows the 3D distribution of the different lung patterns, including Normal (dark green), Mild Low Attenuation Area (LAA, light green), Moderate LAA (light blue), Severe LAA (dark blue), Ground-glass (yellow), Reticular (orange). The glyph f provided by CALIPER summarizes the location and amount of the different lung patterns. The overall area of the glyph represents the computed total lung volume, the partitions with thick radial lines illustrate the relative volumes of the left (L) and right (R) lungs, which are further divided with thin radial lines into three regions, each representing the upper (U), middle (M), lower (L) lung zones. In this patient severe LAA dominates in the right lower and middle lung zones, whereas middle and lower left zones are characterized by mild and moderate LAA
Fig. 2
Fig. 2
The three clusters of COPD patients stratified represented as glyphs. Clusters (G1 to G3) were the result of quantitative unsupervised clustering based on a dissimilarity matrix that captures the distribution of classified parenchymal patterns recognized by CALIPER. G1 was characterized by predominant Normal (dark green) and Mild LAA (light green) patterns, whereas G2 by predominant Moderate LAA (light blue) pattern and G3 by predominant Severe (dark blue) and Moderate LAA (light blue) patterns
Fig. 3
Fig. 3
ROC curve over the range of the ESI model output for severe emphysema a and no emphysema b. Severe emphysema was defined at CT scan as %LAA-950insp ≥ 14 by VIDA whereas no emphysema was defined at CT scan as %LAA-950insp < 6 by VIDA. The total AUC area was of 0.88 for severe emphysema and 0.86 for no emphysema
Fig. 4
Fig. 4
Maximal expiratory flow-volume curves of two representative subjects with severe emphysema or no emphysema. Patient with severe emphysema (left panel) had %LAA-950insp = 24 whereas the patient with no emphysema (right panel) had %LAA-950insp = 4 at CT. Note the flatter slope in the former when flow was plotted against expired volume (black lines) but not pletysmographic thoracic volume (grey lines), indicating greater thoracic gas compression at high-to-mid lung volumes

Similar articles

Cited by

References

    1. Madani A, De Maertelaer V, Zanen J, Gevenois PA. Pulmonary emphysema: radiation dose and section thickness at multidetector CT quantification-comparison with macroscopic and microscopic morphometry. Radiology. 2007;243:250–257. doi: 10.1148/radiol.2431060194. - DOI - PubMed
    1. Hackx M, Bankier AA, Gevenois PA. Chronic obstructive pulmonary disease: CT quantification of airways disease. Radiology. 2012;265:34–48. doi: 10.1148/radiol.12111270. - DOI - PubMed
    1. Galban CJ, Han MK, Boes JL, et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med. 2012;18:1711–1715. doi: 10.1038/nm.2971. - DOI - PMC - PubMed
    1. Aerts HJ. The potential of Radiomic-based phenotyping in precision medicine: a review. JAMA Oncol. 2016;2:1636–1642. doi: 10.1001/jamaoncol.2016.2631. - DOI - PubMed
    1. Raghunath S, Rajagopalan S, Karwoski RA, et al. Quantitative stratification of diffuse parenchymal lung diseases. PLoS One. 2014;9:e93229. doi: 10.1371/journal.pone.0093229. - DOI - PMC - PubMed

Publication types